PrEParing Family Planning Clinics to Streamline Integration of HIV Prevention Services for Young Women in Kenya

  • STATUS
    Recruiting
  • End date
    Dec 31, 2024
  • participants needed
    3600
  • sponsor
    University of Washington
Updated on 28 September 2021
tenofovir
emtricitabine
lamivudine
HIV Vaccine

Summary

This a prospective, open-label implementation project to catalyze integration of HIV prevention and PrEP care services for adolescent girls and young women in family planning clinics in Kenya.

Description

Investigators will conduct a stepped-wedge cluster-randomized programmatic project to integrate PrEP provision within a combination HIV prevention package in 12 family planning clinics in Kisumu, Kenya- a region with an HIV prevalence of up to 28% among young women. The project will optimize and sustain PrEP delivery with existing family planning staff, supported through training and ongoing technical assistance. The investigators will rigorously evaluate program reach, effectiveness, adoption, implementation, maintenance, and impact using validated implementation science frameworks and how clinics build new efficient delivery systems.

Details
Condition STI, HIV Infections, Viral Infections, Viral infection, Primary Immunodeficiency Disorders, Sexually Transmitted Infection, Female Genital Diseases, Immunodeficiency, sexually transmitted diseases, Contraception, Venereal disease, HIV infection, sexually transmitted disease, sexually transmitted infections, Sexually Transmitted Diseases (STDs), contraceptive method, Birth Control, human immunodeficiency virus, hiv disease, birth control method, Gynecological Infections
Treatment PrEP
Clinical Study IdentifierNCT04666792
SponsorUniversity of Washington
Last Modified on28 September 2021

Eligibility

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note